Is Entero Healthcare Solutions Ltd. a good investment? Entero Healthcare Solutions Ltd. (ENTERO.NS) is currently trading at 1088.00 INR. Market analysts have a consensus price target of 1516.75 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 41.50. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Entero Healthcare Solutions Ltd. is expected to release its next earnings report on Aug. 19, 2026. The market consensus estimate for Forward EPS is 55.14.
No, it does not currently pay a dividend.
Entero Healthcare Solutions Ltd. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 19, 2026. The company currently has a trailing EPS of 26.36.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.
Community Discussion